Sweet's syndrome without granulocytosis

International Journal of Dermatology
C ProbertK F Helm

Abstract

Sweet's syndrome (SS), acute febrile neutrophilic dermatosis, has been linked to hematologic malignancies and presents with characteristic edematous dermal plaques. Peripheral blood neutrophilia is frequently seen in association with SS and is one of the diagnostic criteria. To report the clinical, laboratory, and hematologic data of four patients with myeloid leukemia who developed SS after chemotherapy. Three of these patients were neutropenic. A retrospective study of four patients with SS and hematologic malignancies was undertaken. Three patients had de novo acute myelogenous leukemia and one was in the acute blast crisis of chronic myelogenous leukemia. Sweet's syndrome was not originally suspected in these patients because of the low peripheral white blood cell counts caused by chemotherapy. All of the patients presented with fevers, arthralgias, and an eruption. They had been treated with antibiotics because of a presumed infection. Once the correct diagnosis was made and oral prednisolone was started, a rapid response followed. Sweet's syndrome should be considered in the differential diagnosis when acute myeloid leukemic patients develop skin lesions and unexplained fevers regardless of the peripheral blood counts.

Citations

May 1, 2007·Annals of Hematology·Farrukh AwanSteven Devine
May 9, 2000·Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons·M SteinerK Porter
Jun 17, 2000·Clinics in Dermatology·C D Hensley, S W Caughman
Jun 8, 2001·European Journal of Internal Medicine·G NifosìL Cavanna
Mar 22, 2001·Clinical and Experimental Dermatology·C W FarrarJ Ashworth
Feb 15, 2002·Clinical Journal of Oncology Nursing·Carol White
May 6, 2004·Journal of Pediatric Hematology/oncology·Khulood Al-SaadAlberto Pappo
Nov 30, 2000·International Journal of Dermatology·F J GuimeráR García-Montelongo
Feb 27, 2008·Pediatric Blood & Cancer·Kevin Chatham-StephensPeter Kurre
Oct 22, 2014·Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion·Zühre KayaNalan Akyürek
May 31, 2014·Journal of Cutaneous Pathology·Chutika SrisuttiyakornRossitza Lazova

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

The American Journal of Dermatopathology
Thi TranMichael B Morgan
The American Journal of Dermatopathology
P E LeBoit
© 2022 Meta ULC. All rights reserved